Location: Palo Alto, CA
CIK: 0001674712 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.198B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics Inc | 722,020 | $22.76M | 1.9% | — | — | Common | 81728A207 |
| AVBP | Arrivent BioPharma Inc | 885,916 | $20.44M | 1.7% | — | — | Common | 04272N102 |
| MANE | Veradermics Inc | 300,000 | $18.95M | 1.6% | — | — | Common | 922967104 |
| ANTX | AN2 Therapeutics Inc | 3,153,640 | $10.79M | 0.9% | — | — | Common | 037326105 |
| OKUR | Onkure Therapeutics Inc | 1,927,710 | $7.981M | 0.7% | — | — | Common | 68277Q105 |
| ALXO | ALX Oncology Holdings Inc | 3,184,713 | $6.385M | 0.5% | — | — | Common | 00166B105 |
| CMPS | Compass Pathway PLC | 200,000 | $1.106M | 0.1% | — | — | SPONSORED ADS | 20451W101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ERAS | Erasca Inc | 12,151,480 (+31.0%) | $197M (+469.9%) | 16.4% | — | — | Common | 29479A108 |
| CRVS | Corvus Pharmaceuticals Holdings | 2,805,816 (+25.6%) | $41.05M (+138.6%) | 3.4% | — | — | Common | 221015100 |
| PRAX | Praxis Precision Medicines | 338,895 (+3.0%) | $109M (+12.6%) | 9.1% | — | — | Common | 74006W207 |
| DBVT | DBV Technologies SA | 2,667,569 (+8.4%) | $55.73M (+18.1%) | 4.7% | — | — | SPONSORED ADS | 23306J309 |
| DRUG | Bright Minds Biosciences Inc | 557,172 (+11.1%) | $40.66M (+3.9%) | 3.4% | — | — | Common | 10919W405 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Cidara Therapeutics, Inc. | 956,670 | $211M | 17.6% | — | — | — | 171757206 |
| — | Avadel Pharmaceuticals PLC | 2,684,109 | $57.84M | 4.8% | — | — | — | G29687103 |
| ZBIO | Zenas Biopharma Inc | 853,495 | $30.99M | 2.6% | — | — | — | 98937L105 |
| CTMX | Cytomx Therapeutics Inc | 2,884,615 | $12.29M | 1.0% | — | — | — | 23284F105 |
| ABEO | Abeona Therapeutics, Inc. | 1,842,751 | $9.711M | 0.8% | — | — | — | 00289Y206 |
| VSTM | Verastem Inc | 1,106,524 | $8.542M | 0.7% | — | — | — | 92337C203 |
| SLN | Silence Therapeutics PLC | 1,105,454 | $6.721M | 0.6% | — | — | — | 82686Q101 |
| PALI | Palisade Bio Inc | 2,293,578 | $5.39M | 0.4% | — | — | — | 696389402 |
| ENGNW | EnGene Holdings Inc | 285,046 | $844K | 0.1% | — | — | — | 29286M113 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | 1,334,418 (-75.0%) | $70.35M (-67.4%) | 5.9% | — | — | Common | 880881107 |
| COGT | Cogent Biosciences Inc | 422,300 (-82.4%) | $16.25M (-80.9%) | 1.4% | — | — | Common | 19240Q201 |
| SLNO | Soleno Therapeutics Inc | 294,909 (-67.0%) | $9.874M (-76.2%) | 0.8% | — | — | Common | 834203309 |
| VRDN | Viridian Therapeutics Inc | 166,288 (-83.1%) | $3.253M (-89.4%) | 0.3% | — | — | Common | 92790C104 |
| GERN | Geron Corp | 8,671,797 (-68.1%) | $12.92M (-64.0%) | 1.1% | — | — | Common | 374163103 |
| DYN | Dyne Therapeutics Inc | 1,557,466 (-40.4%) | $28.24M (-44.8%) | 2.4% | — | — | Common | 26818M108 |
| ABVX | Abivax SA - ADR | 239,539 (-33.3%) | $26.67M (-45.0%) | 2.2% | — | — | SPONSORED ADS | 00370M103 |
| ORIC | Oric Pharmaceuticals Inc | 1,848,786 (-12.7%) | $23.42M (+35.2%) | 2.0% | — | — | Common | 68622P109 |
| ACRS | Aclaris Therapeutics, Inc. | 6,666,666 (-25.0%) | $25M (-6.6%) | 2.1% | — | — | Common | 00461U105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics Inc | 2,154,780 | $45.08M | 3.8% | — | — | Common | 87583X109 |
| DNTH | Dianthus Therapeutics Inc | 353,998 | $29.71M | 2.5% | — | — | Common | 252828108 |
| PEPG | Pepgen Inc | 2,325,000 | $4.115M | 0.3% | — | — | Common | 713317105 |
| NERV | Minerva Neurosciences Inc | 4,322,747 | $26.04M | 2.2% | — | — | Common | 603380205 |
| CAMP | CAMP4 Therapeutics Inc | 4,246,568 | $18.73M | 1.6% | — | — | Common | 13463J101 |
| OLMA | Olema Pharmaceuticals Inc | 671,843 | $10.02M | 0.8% | — | — | Common | 68062P106 |
| MLTX | Moonlake Immunotherapeutics | 1,000,000 | $18.64M | 1.6% | — | — | Common | 61559X104 |
| ANRO | Alto Neuroscience Inc | 1,035,551 | $23.28M | 1.9% | — | — | Common | 02157Q109 |
| TRVI | Trevi Therapeutics Inc | 5,094,668 | $60.78M | 5.1% | — | — | Common | 89532M101 |
| DSGN | Design Therapeutics Inc | 1,612,903 | $17.16M | 1.4% | — | — | Common | 25056L103 |
| LBRX | LB Pharmaceuticals Inc | 800,000 | $19.73M | 1.6% | — | — | Common | 50180M108 |
| SRZN | Surrozen Inc | 260,000 | $7.574M | 0.6% | — | — | Common | 86889P208 |
| SERA | Sera Prognostics Inc | 1,650,440 | $3.35M | 0.3% | — | — | Common | 81749D107 |
| UNCY | Unicycive Therapeutics | 1,789,916 | $11.78M | 1.0% | — | — | Common | 90466Y202 |
| KTTA | Pasithea Therapeutics Corp | 2,100,000 | $1.558M | 0.1% | — | — | Common | 70261F202 |
| SABS | SAB Biotherapeutics Inc | 11,420,000 | $43.74M | 3.6% | — | — | Common | 78397T202 |
| MNPR | Monopar Therapeutics Inc | 90,500 | $4.958M | 0.4% | — | — | Common | 61023L207 |
| TIL | Instil Bio Inc | 292,743 | $2.412M | 0.2% | — | — | Common | 45783C200 |
| TENX | Tenax Therapeutics Inc | 208,333 | $3.331M | 0.3% | — | — | Common | 88032L605 |
| CMPX | Compass Therapeutics Inc | 9,545,466 | $50.5M | 4.2% | — | — | Common | 20454B104 |
| EPRX | Eupraxia Pharmaceuticals Inc | 1,350,000 | $9.774M | 0.8% | — | — | Common | 29842P105 |
| BOLT | Bolt Therapeutics Inc | 72,414 | $293K | 0.0% | — | — | Common | 097702203 |
| DTIL | Precision Biosciences Inc | 4,675 | $25,713 | 0.0% | — | — | Common | 74019P207 |
| SVA | Sinovac Biotech Ltd. | 5,903,000 | $38.19M | 3.2% | — | — | SHS | P8696W104 |